soybean oil, phospholipid emulsion
(ZACMUBKIFQNSDT-GAUHYDFOSA-O)
Structure
- SMILES
- CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCC/C=C/CCCCCCCC)COP(=O)(OCC[N+](C)(C)C)O.CCCCC/C=C\C/C=C\CCCCCCCC(=O)O
- Molecular Formula:
- C60H115NO10P+
- Molecular Weight:
- 1041.530
- Log P:
- 17.6845
- Hydrogen Bond Acceptor:
- 10
- Hydrogen Bond Donor:
- 2
- TPSA:
- 155.47
- CAS Number(s):
- 68890-65-3
Synonym(s)
1.
soybean oil, phospholipid emulsion
2.
Intrafat
3.
Intralipid
4.
Liposyn III
5.
Travamulsion
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Chills | FAERS: 36 | US FAERS | |
| 2 | Hyperpyrexia | FAERS: 22 | US FAERS | |
| 3 | Chest discomfort | FAERS: 16 | US FAERS | |
| 4 | Temperature intolerance | FAERS: 9 | US FAERS | |
| 5 | Headache | FAERS: 5 | US FAERS | |
| 6 | Nausea | FAERS: 5 | US FAERS | |
| 7 | Palpitations | FAERS: 5 | US FAERS | |
| 8 | Tachycardia | FAERS: 5 | US FAERS | |
| 9 | Anaphylactoid Reaction | FAERS: 4 | US FAERS | |
| 10 | Vomiting | FAERS: 4 | US FAERS | |
| 11 | Device related infection | FAERS: 3 | US FAERS | |
| 12 | Dizziness | FAERS: 3 | US FAERS | |
| 13 | Pallor | FAERS: 3 | US FAERS | |
| 14 | Phlebitis | FAERS: 3 | US FAERS | |
| 15 | Product contamination physical | FAERS: 3 | US FAERS | |
| 16 | Pruritus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Abdominal Pain | FAERS: 2 | US FAERS | |
| 18 | Abdominal discomfort | FAERS: 2 | US FAERS | |
| 19 | Asthenia | FAERS: 2 | US FAERS | |
| 20 | Cold sweat | FAERS: 2 | US FAERS | |
| 21 | Cyanosis | FAERS: 2 | US FAERS | |
| 22 | Medication Error | FAERS: 2 | US FAERS | |
| 23 | Mouth swelling | FAERS: 2 | US FAERS | |
| 24 | Product container issue | FAERS: 2 | US FAERS | |
| 25 | Product quality issue | FAERS: 2 | US FAERS | |
| 26 | Serratia test positive | FAERS: 2 | US FAERS | |
| 27 | Acidosis | FAERS: 1 | US FAERS | |
| 28 | Amylase increased | FAERS: 1 | US FAERS | |
| 29 | Anxiety | FAERS: 1 | US FAERS | |
| 30 | Aortic bruit | FAERS: 1 | US FAERS | |
| 31 | Back Pain | FAERS: 1 | US FAERS | |
| 32 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 33 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 34 | Chest Pain | FAERS: 1 | US FAERS | |
| 35 | Device breakage | FAERS: 1 | US FAERS | |
| 36 | Device malfunction | FAERS: 1 | US FAERS | |
| 37 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 38 | Extravasation | FAERS: 1 | US FAERS | |
| 39 | Fatigue | FAERS: 1 | US FAERS | |
| 40 | Flushing | FAERS: 1 | US FAERS | |
| 41 | Heart sounds abnormal | FAERS: 1 | US FAERS | |
| 42 | Hydrothorax | FAERS: 1 | US FAERS | |
| 43 | Hypotension | FAERS: 1 | US FAERS | |
| 44 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 45 | Intercepted product selection error | FAERS: 1 | US FAERS | |
| 46 | Malaise | FAERS: 1 | US FAERS | |
| 47 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 48 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 49 | Myalgia | FAERS: 1 | US FAERS | |
| 50 | No adverse event | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Overdose | FAERS: 1 | US FAERS | |
| 52 | Parenteral nutrition associated liver disease | FAERS: 1 | US FAERS | |
| 53 | Pericardial effusion | FAERS: 1 | US FAERS | |
| 54 | Product compounding quality issue | FAERS: 1 | US FAERS | |
| 55 | Product label confusion | FAERS: 1 | US FAERS | |
| 56 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 57 | Sepsis | FAERS: 1 | US FAERS | |
| 58 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 59 | Syncope | FAERS: 1 | US FAERS | |
| 60 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 61 | Tremor | FAERS: 1 | US FAERS | |
| 62 | Weight decreased | FAERS: 1 | US FAERS | |
| 63 | Wrong technique in drug usage process | FAERS: 1 | US FAERS | |
| 64 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.